Amarin - 27 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits. The latest closing stock price for Amarin as of July 10, 2020 is 6.72.
  • The all-time high Amarin stock closing price was 1375.00 on July 13, 1993.
  • The Amarin 52-week high stock price is 26.12, which is 288.7% above the current share price.
  • The Amarin 52-week low stock price is 3.95, which is 41.2% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 14.53.
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 11.4476 21.5300 21.5300 4.0000 6.7200 -68.66%
2019 18.2079 13.0100 24.1200 12.6100 21.4400 57.53%
2018 7.2152 4.2400 22.9800 2.4500 13.6100 239.40%
2017 3.3183 3.0900 4.2900 2.8700 4.0100 30.19%
2016 2.3426 1.8100 3.4700 1.2700 3.0800 62.96%
2015 2.0071 1.1300 2.9000 1.0000 1.8900 92.92%
2014 1.5196 1.9600 2.4000 0.8323 0.9797 -50.27%
2013 5.9094 8.1000 9.1600 1.4000 1.9700 -75.65%
2012 11.0818 7.0500 15.4600 6.3500 8.0900 8.01%
2011 10.7040 8.3300 19.5000 6.0300 7.4900 -8.67%
2010 2.6540 1.3800 8.4900 0.9800 8.2010 473.54%
2009 1.1927 0.6800 1.9501 0.5200 1.4299 101.39%
2008 1.9011 2.5000 3.5899 0.6000 0.7100 -72.69%
2007 10.0092 21.8000 37.8000 2.2500 2.6000 -88.60%
2006 26.1466 13.5000 37.4000 12.7000 22.8000 90.00%
2005 17.9218 26.2000 34.0000 10.6000 12.0000 -55.72%
2004 13.8964 15.4000 39.9000 5.3000 27.1000 75.97%
2003 29.0139 39.4000 48.1000 13.9000 15.4000 -61.40%
2002 84.0659 171.0000 210.0000 27.6000 39.9000 -77.03%
2001 132.7548 55.0000 279.7000 50.0000 173.7000 215.82%
2000 59.7940 45.0000 77.8000 37.5000 55.0000 15.79%
1999 70.4238 44.4000 113.8000 41.3000 47.5000 33.43%
1998 103.3595 306.0000 306.0000 10.0000 35.6000 -88.59%
1997 502.1937 581.0000 662.0000 294.0000 312.0000 -46.30%
1996 848.2008 900.0000 1125.0000 550.0000 581.0000 -35.44%
1995 727.3135 650.0000 1000.0000 500.0000 900.0000 38.46%
1994 772.7659 875.0000 1050.0000 481.0000 650.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.590B $0.430B
Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.497B 16.13
Bristol Myers Squibb (BMY) United States $129.946B 10.86
Gilead Sciences (GILD) United States $95.734B 12.41
CSL (CSLLY) Australia $90.156B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.344B 52.49
Regeneron Pharmaceuticals (REGN) United States $68.306B 26.33
Illumina (ILMN) United States $54.427B 55.93
Biogen (BIIB) United States $45.510B 7.79
Seattle Genetics (SGEN) United States $30.180B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $25.051B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.030B 10.32
Moderna (MRNA) United States $23.242B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.796B 206.66
Genmab (GMAB) Denmark $22.796B 18.77
Incyte (INCY) United States $22.772B 0.00
Genmab (GNMSF) Denmark $21.669B 64.33
Alnylam Pharmaceuticals (ALNY) United States $18.717B 0.00
BioNTech SE (BNTX) Germany $15.920B 0.00
BeiGene (BGNE) Cayman Islands $15.246B 0.00
Exact Sciences (EXAS) United States $13.805B 0.00
Sarepta Therapeutics (SRPT) United States $13.165B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Galapagos (GLPG) Belgium $12.513B 36.81
ARGENX SE-ADR (ARGX) Netherlands $11.776B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.918B 26.87
Bio-Techne Corp (TECH) United States $10.412B 68.79
QIAGEN (QGEN) Netherlands $10.319B 30.01
Immunomedics (IMMU) United States $9.541B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.642B 0.00
Guardant Health (GH) United States $8.059B 0.00
Exelixis (EXEL) United States $7.648B 26.82
SWEDISH ORP BIO (BIOVF) Sweden $6.750B 16.79
Repligen (RGEN) United States $6.597B 115.72
Ascendis Pharma (ASND) Denmark $6.573B 0.00
Adaptive Biotechnologies (ADPT) United States $5.828B 0.00
Vir Biotechnology (VIR) United States $5.743B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.544B 119.29
Novavax (NVAX) United States $5.469B 0.00
Acceleron Pharma (XLRN) United States $5.382B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.146B 0.00
Reata Pharmaceuticals (RETA) United States $5.132B 0.00
Zai Lab (ZLAB) China $5.053B 0.00
Mirati Therapeutics (MRTX) United States $5.016B 0.00
Emergent Biosolutions (EBS) United States $4.940B 32.38
MyoKardia (MYOK) United States $4.335B 0.00
Global Blood Therapeutics (GBT) United States $4.334B 0.00
Blueprint Medicines (BPMC) United States $4.279B 0.00
MorphoSys AG (MOR) Germany $4.266B 33.09
China Biologic Products (CBPO) China $4.198B 23.34
Momenta Pharmaceuticals (MNTA) United States $4.037B 0.00
Amicus Therapeutics (FOLD) United States $4.002B 0.00
Halozyme Therapeutics (HALO) United States $3.789B 0.00
NeoGenomics (NEO) United States $3.776B 275.77
Inovio Pharmaceuticals (INO) United States $3.696B 0.00
Bluebird Bio (BLUE) United States $3.561B 0.00
Arena Pharmaceuticals (ARNA) United States $3.318B 0.00
Alkermes (ALKS) Ireland $3.126B 61.53
Deciphera Pharmaceuticals (DCPH) United States $3.030B 0.00
Insmed (INSM) United States $2.813B 0.00
Fate Therapeutics (FATE) United States $2.739B 0.00
Denali Therapeutics (DNLI) United States $2.739B 0.00
PHARMA MAR SA (PHMMF) Spain $2.430B 0.00
Twist Bioscience (TWST) United States $2.242B 0.00
Principia Biopharma (PRNB) United States $2.116B 0.00
UniQure (QURE) Netherlands $2.057B 0.00
Viela Bio (VIE) United States $1.982B 0.00
Eidos Therapeutics (EIDX) United States $1.859B 0.00
Ligand Pharmaceuticals (LGND) United States $1.847B 71.91
Alector (ALEC) United States $1.841B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.840B 0.00
Editas Medicine (EDIT) United States $1.816B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.698B 0.00
Sorrento Therapeutics (SRNE) United States $1.690B 0.00
I-Mab (IMAB) China $1.683B 0.00
Intra-Cellular Therapies (ITCI) United States $1.642B 0.00
Adverum Biotechnologies (ADVM) United States $1.596B 0.00
Epizyme (EPZM) United States $1.532B 0.00
Mesoblast (MESO) Australia $1.517B 0.00
Cytokineticsorporated (CYTK) United States $1.516B 0.00
Zymeworks (ZYME) Canada $1.511B 0.00
Sangamo Therapeutics (SGMO) United States $1.506B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.485B 0.00
Mersana Therapeutics (MRSN) United States $1.444B 0.00
Revance Therapeutics (RVNC) United States $1.410B 0.00
Zealand Pharma (ZEAL) Denmark $1.410B 0.00
REGENXBIO (RGNX) United States $1.385B 0.00
Beam Therapeutics (BEAM) United States $1.376B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NantKwest (NK) United States $1.359B 0.00
Arvinas (ARVN) United States $1.357B 0.00
Akcea Therapeutics (AKCA) United States $1.315B 0.00
NGM Biopharmaceuticals (NGM) United States $1.304B 0.00
Coherus BioSciences (CHRS) United States $1.271B 8.88
Intellia Therapeutics (NTLA) United States $1.223B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.201B 0.00
Arcus Biosciences (RCUS) United States $1.125B 0.00
Compugen (CGEN) Israel $1.085B 0.00
Athenex (ATNX) United States $1.017B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.984B 0.00
Alcobra (ARCT) United States $0.933B 0.00
VBI Vaccines (VBIV) United States $0.904B 0.00
Retrophin (RTRX) United States $0.865B 0.00
Heska (HSKA) United States $0.863B 0.00
Myriad Genetics (MYGN) United States $0.855B 44.12
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.825B 0.00
Pharming Group (PHGUF) Netherlands $0.817B 21.75
Dynavax Technologies (DVAX) United States $0.798B 0.00
Morphic Holding (MORF) United States $0.787B 0.00
Intrexon (PGEN) United States $0.780B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.746B 0.00
Vericel (VCEL) United States $0.724B 133.83
ZIOPHARM Oncology Inc (ZIOP) United States $0.722B 0.00
Castle Biosciences (CSTL) United States $0.719B 0.00
Cellectis S.A (CLLS) France $0.719B 0.00
Frequency Therapeutics (FREQ) United States $0.713B 0.00
Codexis (CDXS) United States $0.676B 0.00
Kadmon Holdings (KDMN) United States $0.674B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.636B 0.00
Agenus (AGEN) United States $0.634B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.627B 5.37
Autolus Therapeutics (AUTL) United Kingdom $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
AnaptysBio (ANAB) United States $0.579B 0.00
MiMedx (MDXG) United States $0.569B 0.00
Kala Pharmaceuticals (KALA) United States $0.554B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.554B 0.00
Athersys (ATHX) United States $0.552B 0.00
Cel-Sci (CVM) United States $0.538B 0.00
Syros Pharmaceuticals (SYRS) United States $0.525B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.516B 0.00
Clovis Oncology (CLVS) United States $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.502B 16.14
NextCure (NXTC) United States $0.492B 0.00
UROGEN PHARMA (URGN) United States $0.488B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 0.00
Scholar Rock Holding (SRRK) United States $0.473B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.466B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.462B 0.00
DBV Technologies S.A (DBVT) France $0.461B 0.00
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
OSMOTICA PHARM (OSMT) United States $0.452B 0.00
Protagonist Therapeutics (PTGX) United States $0.447B 0.00
Geron (GERN) United States $0.437B 0.00
BioDelivery Sciences (BDSI) United States $0.423B 22.21
Precision BioSciences (DTIL) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.418B 0.00
Puma Biotechnology (PBYI) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.395B 0.00
Avid Bioservices (CDMO) United States $0.393B 0.00
CytomX Therapeutics (CTMX) United States $0.391B 0.00
MannKind (MNKD) United States $0.379B 0.00
Kamada (KMDA) Israel $0.377B 15.69
Albireo Pharma (ALBO) United States $0.377B 0.00
WAVE Life Sciences (WVE) Singapore $0.354B 0.00
Affimed (AFMD) Germany $0.336B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 6.53
Seres Therapeutics (MCRB) United States $0.327B 0.00
PDL BioPharma (PDLI) United States $0.320B 280.50
ChromaDex (CDXC) United States $0.314B 0.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.306B 0.00
Gritstone Oncology (GRTS) United States $0.301B 0.00
Prometic Life Sciences (LMNL) Canada $0.293B 0.00
Cellular Biomedicine (CBMG) United States $0.289B 0.00
Pfenex (PFNX) United States $0.281B 0.00
Menlo Therapeutics (MNLO) United States $0.280B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
IBio (IBIO) United States $0.263B 0.00
Celldex Therapeutics (CLDX) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
Abeona Therapeutics (ABEO) United States $0.252B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.244B 0.00
Dyadic (DYAI) United States $0.240B 0.00
Verastem (VSTM) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.229B 0.00
Selecta Biosciences (SELB) United States $0.229B 0.00
IVERIC Bio (ISEE) United States $0.227B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.225B 0.00
Fortress Biotech (FBIO) United States $0.224B 0.00
Five Prime Therapeutics (FPRX) United States $0.223B 0.00
Pluristem Therapeutics (PSTI) Israel $0.216B 0.00
Aduro Biotech (ADRO) United States $0.216B 0.00
Liquidia Technologies (LQDA) United States $0.211B 0.00
XOMA (XOMA) United States $0.210B 0.00
Sutro Biopharma (STRO) United States $0.210B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.208B 3.13
Exicure (XCUR) United States $0.207B 0.00
Aptinyx (APTX) United States $0.205B 0.00
GENFIT S.A (GNFT) France $0.205B 0.00
Strongbridge Biopharma (SBBP) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.177B 0.00
Bellus Health (BLU) Canada $0.177B 0.00
Theratechnologies (THTX) Canada $0.176B 0.00
Trevena (TRVN) United States $0.171B 0.00
Aytu Bioscience (AYTU) United States $0.165B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
TELA Bio (TELA) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Kindred Biosciences (KIN) United States $0.153B 0.00
Applied Genetic Technologies (AGTC) United States $0.150B 0.00
Cyclerion Therapeutics (CYCN) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.132B 0.00
Lumos Pharma (LUMO) United States $0.132B 0.00
Biofrontera AG (BFRA) Germany $0.131B 0.00
Oncobiologics (OTLK) United States $0.130B 0.00
Arbutus Biopharma (ABUS) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 0.00
Palatin Technologies (PTN) United States $0.121B 3.10
Lineage Cell Therapeutics (LCTX) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Celsion (CLSN) United States $0.114B 0.00
Protalix BioTherapeutics (PLX) Israel $0.113B 0.00
AIT Therapeutics (XAIR) United States $0.113B 0.00
AquaBounty Technologies (AQB) United States $0.112B 0.00
Eton Pharmaceuticals (ETON) United States $0.106B 0.00
Unum Therapeutics (UMRX) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Cardiff Oncology (CRDF) United States $0.094B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.094B 0.00
Windtree Therapeutics (WINT) United States $0.093B 0.00
Cocrystal Pharma (COCP) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
DiaMedica Therapeutics (DMAC) United States $0.087B 0.00
Adocia (ADOCY) France $0.080B 0.00
Organovo Holdings (ONVO) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
Catalyst Biosciences (CBIO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.067B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
AnPac Bio-Medical Science (ANPC) China $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
Signal Genetics (MGEN) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Curis (CRIS) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Advaxis (ADXS) United States $0.035B 0.00
OvaScience (MLND) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.031B 0.00
Cesca Therapeutics (THMO) United States $0.031B 0.00
Spherix (AIKI) United States $0.031B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
BioPharmX (TMBR) United States $0.027B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
IMMURON (IMRN) Australia $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
BioCardia (BCDA) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00